FERRI, Clodoveo
 Distribuzione geografica
Continente #
NA - Nord America 34.463
EU - Europa 21.386
AS - Asia 6.144
SA - Sud America 81
Continente sconosciuto - Info sul continente non disponibili 37
AF - Africa 32
OC - Oceania 32
Totale 62.175
Nazione #
US - Stati Uniti d'America 34.281
GB - Regno Unito 8.752
IT - Italia 5.653
CN - Cina 1.960
SE - Svezia 1.838
SG - Singapore 1.685
UA - Ucraina 1.344
DE - Germania 1.332
TR - Turchia 1.258
HK - Hong Kong 744
FI - Finlandia 724
FR - Francia 711
BG - Bulgaria 490
IE - Irlanda 142
RU - Federazione Russa 106
CA - Canada 94
ID - Indonesia 85
IN - India 75
VN - Vietnam 72
BZ - Belize 65
IR - Iran 58
BE - Belgio 55
JP - Giappone 52
KR - Corea 45
NL - Olanda 41
MY - Malesia 40
EU - Europa 34
RO - Romania 31
AU - Australia 26
LT - Lituania 25
AR - Argentina 24
PL - Polonia 24
CH - Svizzera 22
ES - Italia 21
MX - Messico 21
BR - Brasile 18
CL - Cile 16
TW - Taiwan 16
ZA - Sudafrica 15
CZ - Repubblica Ceca 12
PK - Pakistan 11
SA - Arabia Saudita 10
CO - Colombia 9
HU - Ungheria 9
GR - Grecia 8
IL - Israele 8
PT - Portogallo 8
IQ - Iraq 7
NO - Norvegia 7
EG - Egitto 6
LU - Lussemburgo 6
NZ - Nuova Zelanda 6
PE - Perù 6
TH - Thailandia 6
AT - Austria 5
VE - Venezuela 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DK - Danimarca 3
MA - Marocco 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
BO - Bolivia 2
BY - Bielorussia 2
LV - Lettonia 2
MD - Moldavia 2
MK - Macedonia 2
PH - Filippine 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AZ - Azerbaigian 1
CM - Camerun 1
CR - Costa Rica 1
DZ - Algeria 1
EC - Ecuador 1
ET - Etiopia 1
GH - Ghana 1
GN - Guinea 1
IM - Isola di Man 1
JO - Giordania 1
KZ - Kazakistan 1
ME - Montenegro 1
MN - Mongolia 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
RS - Serbia 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
VA - Santa Sede (Città del Vaticano) 1
Totale 62.175
Città #
Southend 7.726
Fairfield 5.007
Woodbridge 3.478
Jacksonville 2.747
Houston 2.633
Ashburn 2.236
Chandler 2.065
Ann Arbor 1.930
Seattle 1.775
Dearborn 1.674
Wilmington 1.663
Cambridge 1.604
Singapore 1.325
Nyköping 1.083
Izmir 821
Hong Kong 736
Beijing 614
Modena 591
Princeton 523
San Diego 523
Sofia 486
Eugene 448
Milan 414
Rome 348
Helsinki 302
New York 274
Des Moines 245
Los Angeles 208
London 180
Redwood City 179
Bremen 169
Atlanta 151
San Jose 126
Shanghai 117
Dublin 114
Norwalk 110
Boardman 108
Bologna 101
Falls Church 93
Florence 92
Jakarta 81
Palermo 80
Belize City 65
Turin 65
Guangzhou 64
Naples 64
Frankfurt am Main 62
Hefei 62
Nanjing 62
Dong Ket 56
Catania 54
Verona 54
Bari 51
Dallas 50
Brussels 49
Genoa 49
Santa Clara 47
Kunming 46
Hounslow 44
Jinan 43
Padova 43
San Mateo 37
Toronto 37
Cagliari 35
Indiana 35
Kilburn 34
Chicago 33
Chiswick 33
Munich 33
Saint Louis 32
Mountain View 31
Parma 31
Ottawa 30
Tehran 26
Brescia 25
Philadelphia 24
Phoenix 22
Reggio Emilia 22
Saint Petersburg 22
Salerno 22
San Francisco 21
Prescot 20
Napoli 19
Treviso 18
Pisa 17
Shenyang 17
Torino 17
Wuhan 17
Leawood 16
Pescara 16
Acton 15
Columbus 15
Fuzhou 15
Trento 15
Augusta 14
Bergamo 14
Forlì 14
Hangzhou 14
Legnano 14
Messina 14
Totale 47.096
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.096
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 696
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 676
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 629
Semeiotica dell'articolazione temporo-mandibolare 373
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 368
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 284
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 276
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 245
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 244
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 238
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 235
Current treatment of hepatitis C-associated rheumatic diseases. 227
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 227
Elevated Troponin Serum Levels in Adult Onset Still's Disease 226
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 223
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 223
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 213
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 212
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 210
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 206
GISEA: an Italian biological agents registry in rheumatology 205
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 205
Aortic pulse wave velocity measurement in systemic sclerosis patients. 202
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 200
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 200
Cardiac Involvement in Systemic Vasculitis 199
Large Vessel Vasculitis Occurring in Rheumatoid Arthritis Patient under Anti-TNF Therapy 199
Cytokines and HCV-Related Disorders. 197
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 196
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 194
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 194
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 193
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature 193
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 190
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 188
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 188
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 188
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study 187
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 187
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 186
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 185
Correlation of articular involvement, skin disfigurement, and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample 183
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 183
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 182
HCV-related rheumatic manifestations and therapeutic strategies 182
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature. 182
New targeted molecular therapies for dedifferentiated thyroid cancer 182
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 180
B-cells and mixed cryoglobulinemia 180
Associations between Systemic Sclerosis and Thyroid Diseases 180
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 179
Validation of the classification criteria for cryoglobulinaemic vasculitis 178
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 177
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 176
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 175
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis. 175
SAT0633-HPR Articular Involvement of the Scleroderma Hand: An Assessment Protocol for Planning Occupational Therapy Strategies 174
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 173
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides 170
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 170
Efficacy of Belimumab for active lupus nephritis in a young Hispanic woman intolerant to standard treatment: a case report 170
Renal Manifestations of Hepatitis C Virus 168
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement 167
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 167
The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients 166
Epstein-barr virus reactivation after infliximab in rheumatoid arthritis: a case report. 166
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 165
Scleroderma digital ulcers complicated by infection with fecal pathogens. 164
Endocrine Manifestations of HCV-Positive Cryoglobulinemia 164
Endocrine manifestations of hepatitis C virus infection. 164
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 162
Heart involvement and systemic sclerosis 161
Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis 161
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 161
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 161
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 161
Phantom Limb Pain in Patients with Severe Cryoglobulinemic Vasculitis: Usefulness of Long-Term Pregabalin Treatment 160
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 160
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 160
High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection 160
The Expanding Spectrum of Clinical Features in HCV-Related Mixed Cryoglobulinemia 159
Treatment of HCV-related mixed cryoglobulinemia 159
Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: The glucocorticoid induced OsTeoporosis TOol (GIOTTO) study 159
Hepatitis C virus infection and chronic kidney disease: Time for reappraisal 159
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 159
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis 159
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 158
IP-10 in autoimmune thyroiditis 157
Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer 156
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study 155
Diffuse post-traumatic calcification of the anterior longitudinal ligamentum of cervical and dorsal spine 155
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 155
Amlodipine in the treatment of Raynaud's phenomenon 154
Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictors 154
Systemic sclerosis following human cytomegalovirus infection 153
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 153
Novel Therapies for Thyroid Autoimmune Diseases 153
International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement 153
Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection 153
Totale 23.015
Categoria #
all - tutte 277.445
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 277.445


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010.522 0 0 0 0 1.321 2.398 1.879 1.904 1.245 458 767 550
2020/202110.327 877 362 782 981 1.068 939 959 1.702 405 1.070 658 524
2021/20227.902 212 961 816 688 225 438 427 430 891 607 1.239 968
2022/20237.691 1.000 615 410 558 962 1.174 370 689 963 183 469 298
2023/20246.193 242 364 373 611 1.307 501 594 655 145 384 413 604
2024/20252.592 663 224 296 1.315 94 0 0 0 0 0 0 0
Totale 62.907